The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells
Open accessAbstract
Loss of stromal fibroblast caveolin-1 (Cav-1) is a powerful single independent predictor of poor prognosis in human breast cancer patients, and is associated with early tumor recurrence, lymph node metastasis and tamoxifen-resistance. We developed a novel co-culture system to understand the mechanism(s) by which a loss of stromal fibroblast Cav-1 induces a "lethal tumor micro-environment." Here, we propose a new paradigm to explain the powerful prognostic value of stromal Cav-1. In this model, cancer cells induce oxidative stress in cancer-associated fibroblasts, which then acts as a "metabolic" and "mutagenic" motor to drive tumor-stroma co-evolution, DNA damage and aneuploidy in cancer cells. More specifically, we show that an acute loss of Cav-1 expression leads to mitochondrial dysfunction, oxidative stress and aerobic glycolysis in cancer associated fibroblasts. Also, we propose that defective mitochondria are removed from cancer-associated fibroblasts by autophagy/mitophagy that is induced by oxidative stress. As a consequence, cancer associated fibroblasts provide nutrients (such as lactate) to stimulate mitochondrial biogenesis and oxidative metabolism in adjacent cancer cells (the "Reverse Warburg Effect"). We provide evidence that oxidative stress in cancer-associated fibroblasts is sufficient to induce genomic instability in adjacent cancer cells, via a bystander effect, potentially increasing their aggressive behavior. Finally, we directly demonstrate that nitric oxide (NO) over-production, secondary to Cav-1 loss, is the root cause for mitochondrial dysfunction in cancer associated fibroblasts. In support of this notion, treatment with anti-oxidants (such as N-acetyl-cysteine, metformin and quercetin) or NO inhibitors (L-NAME) was sufficient to reverse many of the cancer-associated fibroblast phenotypes that we describe. Thus, cancer cells use "oxidative stress" in adjacent fibroblasts (i) as an "engine" to fuel their own survival via the stromal production of nutrients and (ii) to drive their own mutagenic evolution towards a more aggressive phenotype, by promoting genomic instability. We also present evidence that the "field effect" in cancer biology could also be related to the stromal production of ROS and NO species. eNOS-expressing fibroblasts have the ability to downregulate Cav-1 and induce mitochondrial dysfunction in adjacent fibroblasts that do not express eNOS. As such, the effects of stromal oxidative stress can be laterally propagated, amplified and are effectively "contagious"--spread from cell-to-cell like a virus--creating an "oncogenic/mutagenic" field promoting widespread DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, J., Ying, G., Wang, J., Jung, Y., Lu, J., Zhu, J., Pienta, K. J., & Taichman, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2863 · Cited by 96
RetractedRetracted: Elevated expression of CaMKIIγ during osteoclastogenesis and its functional implications
Yao, C., Stern, P. H., & Zhang, L. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21155 · Cited by 47
RetractedKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Self-citationCaveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,158
Self-citationThe antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin
Garcı́a-Cardeña, G., Martasek, P., Masters, B. S. S., Skidd, P. M., Couet, J., Li, S., Lisanti, M. P., & Sessa, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25437 · Cited by 821
Self-citationUshio-Fukai, M., Zafari, A. M., Fukui, T., Ishizaka, N., & Griendling, K. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23317 · Cited by 767
Razani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 639
Self-citationDegradation of Misfolded Proteins Prevents ER-Derived Oxidative Stress and Cell Death
Haynes, C. M., Titus, E. A., & Cooper, A. A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.025 · Cited by 627
García-Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.004 · Cited by 523
Reduction of caveolin and caveolae in oncogenically transformed cells.
Koleske, A. J., Baltimore, D., & Lisanti, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1381 · Cited by 499
Self-citationA novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase
Melov, S., Schneider, J. A., Day, B. J., Hinerfeld, D., Coskun, P., Mirra, S. S., Crapo, J. D., & Wallace, D. C. (1998) · Nature Genetics · doi:10.1038/ng0298-159 · Cited by 489
Galbiati, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6633 · Cited by 471
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
Gallo, O., Fini-Storchi, I., Vergari, W. A., Masini, E., Morbidelli, L., Ziche, M., & Franchi, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.587 · Cited by 427
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., & Schnitzer, J. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201661 · Cited by 421
Pitkanen, S., & Robinson, B. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118798 · Cited by 388
Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16374 · Cited by 369
Self-citationBeckman, K. B., & Ames, B. N. (2000) · Handbook of Oxidants and Antioxidants in Exercise · doi:10.1016/b978-044482650-3/50027-4 · Cited by 307
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
Morales, A. I., Detaille, D., Prieto, M., Puente, A., Briones, E., Arévalo, M., Leverve, X., López-Novoa, J. M., & El-Mir, M.-Y. (2010) · Kidney International · doi:10.1038/ki.2010.11 · Cited by 284
Witkiewicz, A. K., Dasgupta, A., Sotgia, F., Mercier, I., Pestell, R. G., Sabel, M., Kleer, C. G., Brody, J. R., & Lisanti, M. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080873 · Cited by 283
Self-citationBatandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
Accumulation of HIF-1α under the influence of nitric oxide
Sandau, K. B., Fandrey, J., & Brüne, B. (2001) · Blood · doi:10.1182/blood.v97.4.1009 · Cited by 265
Nitric oxide, an autocrine regulator of wound fibroblast synthetic function
Schäffer, M. R., Efron, P. A., Thornton, F. J., Klingel, K., Gross, S. S., & Barbul, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2375 · Cited by 260
Martinez-Outschoorn, U. E., Pavlides, S., Whitaker-Menezes, D., Daumer, K. M., Milliman, J. N., Chiavarina, B., Migneco, G., Witkiewicz, A. K., Martinez-Cantarin, M. P., Flomenberg, N., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12048 · Cited by 246
Self-citationUltrastructure of the Mitochondrion and Its Bearing on Function and Bioenergetics
Benard, G., & Rossignol, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.2000 · Cited by 241
Pavlides, S., Tsirigos, A., Vera, I., Flomenberg, N., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., Pestell, R. G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.11.11848 · Cited by 217
Self-citationNitric oxide drives skin repair: Novel functions of an established mediator
Frank, S., Kämpfer, H., Wetzler, C., & Pfeilschifter, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00237.x · Cited by 216
Ugalde, C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh071 · Cited by 215
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression
Knudsen, E. S., Buckmaster, C., Chen, T.-T., Feramisco, J. R., & Wang, J. Y. J. (1998) · Genes & Development · doi:10.1101/gad.12.15.2278 · Cited by 210
Self-citationWang, X., Allen, T. D., May, R. J., Lightfoot, S., Houchen, C. W., & Huycke, M. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1551 · Cited by 205
Vakkala, M. A., Kahlos, K., Lakari, E., Pääkkö, P. K., Kinnula, V. L., & Soini, Y. (2000) · PubMed · Cited by 196
Palmer, L. A., Gaston, B., & Johns, R. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12688-0 · Cited by 193
Morris, M. E., & Felmlee, M. A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9035-6 · Cited by 192
Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer
Sloan, E. K., Ciocca, D. R., Pouliot, N., Natoli, A., Restall, C., Henderson, M. A., Fanelli, M. A., Cuello-Carrión, F. D., Gago, F. E., & Anderson, R. L. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080924 · Cited by 191
Intrinsic Mutagenesis: A Genetic Basis of Ageing
Burnet, F. M. (1974) · Pathology · doi:10.3109/00313027409077150 · Cited by 180
Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature
Andrade, S. P., Hart, I. R., & Piper, P. J. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13412.x · Cited by 175
Wang, R., Ghahary, A., Shen, Y. J., Scott, P. G., & Tredget, E. E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12343428 · Cited by 167
Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
Dakhova, O., Ozen, M., Creighton, C. J., Li, R., Ayala, G., Rowley, D., & Ittmann, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1899 · Cited by 166
Mercier, I., Casimiro, M. C., Wang, C., Rosenberg, A., Quong, J. N., Minkeu, A., Allen, K. G., Danilo, C., Sotgia, F., Bonuccelli, G., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.8.6220 · Cited by 161
Self-citationPavlides, S., Tsirigos, A., Vera, I., Flomenberg, N., Frank, P. G., Casimiro, M. C., Wang, C., Pestell, R. G., Martinez‐Outschoorn, U., Howell, A., et al. (2010) · Aging · doi:10.18632/aging.100134 · Cited by 155
Self-citationRelationships between caveolae and eNOS: everything in proximity and the proximity of everything
Goligorsky, M. S., Li, H., Brodsky, S. V., & Chen, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00377.2001 · Cited by 152
Evidence for field cancerization of the prostate
Nonn, L., Ananthanarayanan, V., & Gann, P. H. (2009) · The Prostate · doi:10.1002/pros.20983 · Cited by 151
Reliene, R., Fischer, E., & Schiestl, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0442 · Cited by 146
Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas
Izawa, T., Obara, T., Tanno, S., Mizukami, Y., Yanagawa, N., & Kohgo, Y. (2001) · Cancer · doi:10.1002/1097-0142(20011001)92:7<1807::aid-cncr1697>3.0.co;2-0 · Cited by 141
Seemayer, T. A., Schürch, W., Lagacé, R., & Tremblay, G. (1979) · The American Journal of Surgical Pathology · doi:10.1097/00000478-197912000-00005 · Cited by 140
Vizio, D. D., Morello, M., Sotgia, F., Pestell, R. G., Freeman, M. R., & Lisanti, M. P. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9116 · Cited by 139
Self-citationPostischemic inhibition of cerebral cortex pyruvate dehydrogenase
Bogaert, Y. E., Rosenthal, R. E., & Fiskum, G. M. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90197-x · Cited by 135
Nakamura, Y., Yasuoka, H., Tsujimoto, M., Yoshidome, K., Nakahara, M., Nakao, K., Nakamura, M., & Kakudo, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1269 · Cited by 133
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
Witkiewicz, A. K., Dasgupta, A., Nguyen, K., Liu, C., Kovatich, A. J., Schwartz, G. F., Pestell, R. G., Sotgia, F., Rui, H., & Lisanti, M. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8874 · Cited by 128
Self-citationWitkiewicz, A. K., Dasgupta, A., Sammons, S., Er, O. S., Potoczek, M., Guiles, F., Sotgia, F., Brody, J. R., Mitchell, E. P., & Lisanti, M. P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.2.11983 · Cited by 127
Self-citationSotgia, F., Galdo, F. D., Casimiro, M. C., Bonuccelli, G., Mercier, I., Whitaker‐Menezes, D., Daumer, K. M., Zhou, J., Wang, C., Katiyar, S., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080658 · Cited by 125
Self-citationCaveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation
Liu, J., Lee, P., Galbiati, F., Kitsis, R. N., & Lisanti, M. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c823 · Cited by 122
Self-citationThe Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete Resection
Höckel, M., & Dornhöfer, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3868 · Cited by 114
Gstraunthaler, G. J. A., Seppi, T., & Pfaller, W. (1999) · Cellular Physiology and Biochemistry · doi:10.1159/000016312 · Cited by 112
Hong, C., Ambrosone, C. B., Ahn, J., Choi, J., McCullough, M. L., Stevens, V. L., Rodriguez, C., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0247 · Cited by 106
Heaphy, C. M., Bisoffi, M., Fordyce, C., Haaland, C. M., Hines, W. C., Joste, N. E., & Griffith, J. K. (2006) · International Journal of Cancer · doi:10.1002/ijc.21815 · Cited by 102
Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice
Reliene, R., & Schiestl, R. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi222 · Cited by 101
Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice
Reliene, R., & Schiestl, R. H. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.003 · Cited by 100
And now for something completely different?
Brown, D. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00174.2002 · Cited by 78
Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3
Shi, Y., Pritchard, K. A., Holman, P., Rafiee, P., Griffith, O. W., Kalyanaraman, B., & Baker, J. E. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00364-6 · Cited by 65
Orucevic, A., & Lala, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.34 · Cited by 62
Antioxidants Suppress Lymphoma and Increase Longevity in Atm-Deficient Mice ,3
Reliene, R., & Schiestl, R. H. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.229s · Cited by 53
COBBOLD, C. A., & Sherratt, J. A. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2012 · Cited by 49
Peroxiredoxin I and II inhibit H2O2‐induced cell death in MCF‐7 cell lines
Bae, J., Ahn, S., Han, W., & Noh, D. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21241 · Cited by 47
Yang, J., Ambrosone, C. B., Hong, C.-C., Ahn, J., Rodríguez, C., Thun, M. J., & Calle, E. E. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm016 · Cited by 43
Berridge, M. V., & Tan, A. S. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0948 · Cited by 40
Could stroma contribute to field cancerization?
Ge, L., Meng, W., Zhou, H., & Bhowmick, N. A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.01.019 · Cited by 34
Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis
Karihtala, P., Winqvist, R., Syväoja, J. E., Kinnula, V. L., & Soini, Y. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.037 · Cited by 34
The role of nitric oxide in the formation of keloid and hypertrophic lesions
Cobbold, C. A. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1373 · Cited by 33
Ottesen, G. L. (2003) · PubMed · Cited by 33
Iwasaki, T., Higashiyama, M., Kuriyama, K., Sasaki, A., Mukai, M., Shinkai, K., Horai, T., Matsuda, H., & Akedo, H. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00462.x · Cited by 31
Effects of NG-nitro-l-arginine and/or l-arginine on experimental pulmonary metastasis in mice
Yamamoto, T., Terada, N., Nishizawa, Y., Tanaka, H., Akedo, H., Seiyama, A., Shiga, T., & Kosaka, H. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90417-0 · Cited by 27
Association Between Nitrotyrosine Levels and Microvascular Density in Human Breast Cancer
Samoszuk, M. K., Brennan, M., To, V., Leonor, L., Zheng, L., Fu, X., & Hazen, S. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016328526866 · Cited by 22
Martin, K. R., Saulnier, M., Kari, F. W., Barrett, J. C., & French, J. E. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc431_7 · Cited by 10
mitoEnergetics and cancer cell fate
Chen, Z. X., Velaithan, R., & Pervaiz, S. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.12.009 · Cited by 6
Cited by
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Self-citationMetabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Metadata
- Authors
- Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D., Chiavarina, B., Pavlides, S., Wang, C., Whitaker-Menezes, D., Daumer, K., Lin, Z., Witkiewicz, A., Flomenberg, N., Howell, A., Pestell, R., Knudsen, E., Sotgia, F., & Lisanti, M. P.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2010-08-15
- Volume
- 9
- Issue
- 16
- Pages
- 3276-3296
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2159494912
- Cited by
- 460
- References
- 86
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.